We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00112281
Recruitment Status : Terminated
First Posted : June 2, 2005
Last Update Posted : August 4, 2006
Sponsor:
Information provided by:
Arginox Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Terminated
Primary Completion Date : No date given
Study Completion Date : January 2007
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):